Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2011 Apr;63(4):535–541. doi: 10.1002/acr.20365

Table 2.

Neopterin Concentrations in Patients with SLE and RA and Current Medications

Current Medication Use Neopterin (SLE) Neopterin (RA)
n (nmol/l) P* n (nmol/l) P*
Corticosteroids
No 63 7.6 [5.9–9.8] 0.21 76 6.6 [5.4–8.6] 0.94
Yes 85 8.5 [7.1–9.8] 90 7.0 [4.9–8.9]
Methotrexate
No 134 8.0 [6.5–9.8] 0.87 48 7.6 [6.0–10.7] 0.01
Yes 14 8.6 [7.1–11.7] 118 6.4 [4.9–8.3]
Antimalarials
No 49 8.7 [7.3–12.2] 0.03 124 7.1 [5.5–9.3] 0.12
Yes 99 7.7 [6.3–9.3] 42 5.8 [4.8–7.5]
Anti-TNF agents
No - - - 132 6.9 [5.3–9.2] 0.18
Yes - - - 34 6.2 [5.0–8.0]
*

Adjusted P value for age, sex, race, serum creatinine and the current use of other drugs.